Blood cancers, or hematologic cancers, affect the production and function of blood cells. Most of these cancers start in the bone marrow where blood is produced.
Scope of the Report:
This report focuses on the Blood Cancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Blood Cancer Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Amgen Inc,
- AstraZeneca PLC,
- Astellas Pharma Inc,
- Bayer AG,
- Bristol-Myers Squibb Company,
- Celgene Corporation,
- Eli Lilly,
- F.Hoffmann-La Roche Ltd.,
- Johnson & Johnson,
- Novartis,
- Pfizer Inc,
- Takeda Pharmaceutical Company Ltd,
- AbbVie Inc.
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Blood Chemotherapy Drugs
- Blood Targeted Therapy Drugs
Market Segment by Applications, can be divided into
- Leukemia
- lymphoma
- Multiple Myeloma
There are 15 Chapters to deeply display the global Blood Cancer Drugs market.
Chapter 1, to describe Blood Cancer Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Blood Cancer Drugs, with sales, revenue, and price of Blood Cancer Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Blood Cancer Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Blood Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Blood Cancer Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Blood Cancer Drugs Market 2018, Forecast to 2023
Table of Contents
1 Market Overview
1.1 Blood Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Blood Chemotherapy Drugs
1.2.2 Blood Targeted Therapy Drugs
1.3 Market Analysis by Applications
1.3.1 Leukemia
1.3.2 lymphoma
1.3.3 Multiple Myeloma
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen Inc,
2.1.1 Business Overview
2.1.1.1 Amgen Inc, Description
2.1.1.2 Amgen Inc, Headquarter, Main Business and Finance Overview
2.1.2 Amgen Inc, Blood Cancer Drugs Product Introduction
2.1.2.1 Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
2.1.2.2 Blood Cancer Drugs Product Information
2.1.3 Amgen Inc, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Amgen Inc, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Amgen Inc, Blood Cancer Drugs Market Share in 2017
2.2 AstraZeneca PLC,
2.2.1 Business Overview
2.2.1.1 AstraZeneca PLC, Description
2.2.1.2 AstraZeneca PLC, Headquarter, Main Business and Finance Overview
2.2.2 AstraZeneca PLC, Blood Cancer Drugs Product Introduction
2.2.2.1 Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
2.2.2.2 Blood Cancer Drugs Product Information
2.2.3 AstraZeneca PLC, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 AstraZeneca PLC, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global AstraZeneca PLC, Blood Cancer Drugs Market Share in 2017
2.3 Astellas Pharma Inc,
2.3.1 Business Overview
2.3.1.1 Astellas Pharma Inc, Description
2.3.1.2 Astellas Pharma Inc, Headquarter, Main Business and Finance Overview
2.3.2 Astellas Pharma Inc, Blood Cancer Drugs Product Introduction
2.3.2.1 Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
2.3.2.2 Blood Cancer Drugs Product Information
2.3.3 Astellas Pharma Inc, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Astellas Pharma Inc, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Astellas Pharma Inc, Blood Cancer Drugs Market Share in 2017
2.4 Bayer AG,
2.4.1 Business Overview
2.4.1.1 Bayer AG, Description
2.4.1.2 Bayer AG, Headquarter, Main Business and Finance Overview
2.4.2 Bayer AG, Blood Cancer Drugs Product Introduction
2.4.2.1 Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
2.4.2.2 Blood Cancer Drugs Product Information
2.4.3 Bayer AG, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Bayer AG, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Bayer AG, Blood Cancer Drugs Market Share in 2017
2.5 Bristol-Myers Squibb Company,
2.5.1 Business Overview
2.5.1.1 Bristol-Myers Squibb Company, Description
2.5.1.2 Bristol-Myers Squibb Company, Headquarter, Main Business and Finance Overview
2.5.2 Bristol-Myers Squibb Company, Blood Cancer Drugs Product Introduction
2.5.2.1 Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
2.5.2.2 Blood Cancer Drugs Product Information
2.5.3 Bristol-Myers Squibb Company, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Bristol-Myers Squibb Company, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Bristol-Myers Squibb Company, Blood Cancer Drugs Market Share in 2017
2.6 Celgene Corporation,
2.6.1 Business Overview
2.6.1.1 Celgene Corporation, Description
2.6.1.2 Celgene Corporation, Headquarter, Main Business and Finance Overview
2.6.2 Celgene Corporation, Blood Cancer Drugs Product Introduction
2.6.2.1 Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
2.6.2.2 Blood Cancer Drugs Product Information
2.6.3 Celgene Corporation, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Celgene Corporation, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Celgene Corporation, Blood Cancer Drugs Market Share in 2017
2.7 Eli Lilly,
2.7.1 Business Overview
2.7.1.1 Eli Lilly, Description
2.7.1.2 Eli Lilly, Headquarter, Main Business and Finance Overview
2.7.2 Eli Lilly, Blood Cancer Drugs Product Introduction
2.7.2.1 Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
2.7.2.2 Blood Cancer Drugs Product Information
2.7.3 Eli Lilly, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Eli Lilly, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Eli Lilly, Blood Cancer Drugs Market Share in 2017
2.8 F.Hoffmann-La Roche Ltd.,
2.8.1 Business Overview
2.8.1.1 F.Hoffmann-La Roche Ltd., Description
2.8.1.2 F.Hoffmann-La Roche Ltd., Headquarter, Main Business and Finance Overview
2.8.2 F.Hoffmann-La Roche Ltd., Blood Cancer Drugs Product Introduction
2.8.2.1 Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
2.8.2.2 Blood Cancer Drugs Product Information
2.8.3 F.Hoffmann-La Roche Ltd., Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 F.Hoffmann-La Roche Ltd., Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global F.Hoffmann-La Roche Ltd., Blood Cancer Drugs Market Share in 2017
2.9 Johnson & Johnson,
2.9.1 Business Overview
2.9.1.1 Johnson & Johnson, Description
2.9.1.2 Johnson & Johnson, Headquarter, Main Business and Finance Overview
2.9.2 Johnson & Johnson, Blood Cancer Drugs Product Introduction
2.9.2.1 Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
2.9.2.2 Blood Cancer Drugs Product Information
2.9.3 Johnson & Johnson, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Johnson & Johnson, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Johnson & Johnson, Blood Cancer Drugs Market Share in 2017
2.10 Novartis,
2.10.1 Business Overview
2.10.1.1 Novartis, Description
2.10.1.2 Novartis, Headquarter, Main Business and Finance Overview
2.10.2 Novartis, Blood Cancer Drugs Product Introduction
2.10.2.1 Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
2.10.2.2 Blood Cancer Drugs Product Information
2.10.3 Novartis, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Novartis, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Novartis, Blood Cancer Drugs Market Share in 2017
2.11 Pfizer Inc,
2.11.1 Business Overview
2.11.2 Pfizer Inc, Blood Cancer Drugs Product Introduction
2.11.3 Pfizer Inc, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Takeda Pharmaceutical Company Ltd,
2.12.1 Business Overview
2.12.2 Takeda Pharmaceutical Company Ltd, Blood Cancer Drugs Product Introduction
2.12.3 Takeda Pharmaceutical Company Ltd, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 AbbVie Inc.
2.13.1 Business Overview
2.13.2 AbbVie Inc. Blood Cancer Drugs Product Introduction
2.13.3 AbbVie Inc. Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Blood Cancer Drugs Market Competition, by Manufacturer
3.1 Global Blood Cancer Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Blood Cancer Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Blood Cancer Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Blood Cancer Drugs Manufacturer Market Share in 2017
3.4.2 Top 5 Blood Cancer Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Blood Cancer Drugs Market Analysis by Regions
4.1 Global Blood Cancer Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Blood Cancer Drugs Sales by Regions (2013-2018)
4.1.2 Global Blood Cancer Drugs Revenue by Regions (2013-2018)
4.2 North America Blood Cancer Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Blood Cancer Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Blood Cancer Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Blood Cancer Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Blood Cancer Drugs Sales, Revenue and Growth Rate (2013-2018)
5 North America Blood Cancer Drugs by Countries, Type, Application and Manufacturers
5.1 North America Blood Cancer Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Blood Cancer Drugs Sales by Countries (2013-2018)
5.1.2 North America Blood Cancer Drugs Revenue by Countries (2013-2018)
5.1.3 United States Blood Cancer Drugs Sales and Growth Rate (2013-2018)
5.1.4 Canada Blood Cancer Drugs Sales and Growth Rate (2013-2018)
5.1.5 Mexico Blood Cancer Drugs Sales and Growth Rate (2013-2018)
5.2 North America Blood Cancer Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Blood Cancer Drugs Sales by Manufacturers (2016-2017)
5.2.2 North America Blood Cancer Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Blood Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Blood Cancer Drugs Sales and Sales Share by Type (2013-2018)
5.3.2 North America Blood Cancer Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Blood Cancer Drugs Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Blood Cancer Drugs Sales and Sales Share by Application (2013-2018)
5.4.2 North America Blood Cancer Drugs Revenue and Revenue Share by Application (2013-2018)
6 Europe Blood Cancer Drugs by Countries, Type, Application and Manufacturers
6.1 Europe Blood Cancer Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Blood Cancer Drugs Sales by Countries (2013-2018)
6.1.2 Europe Blood Cancer Drugs Revenue by Countries (2013-2018)
6.1.3 Germany Blood Cancer Drugs Sales and Growth Rate (2013-2018)
6.1.4 UK Blood Cancer Drugs Sales and Growth Rate (2013-2018)
6.1.5 France Blood Cancer Drugs Sales and Growth Rate (2013-2018)
6.1.6 Russia Blood Cancer Drugs Sales and Growth Rate (2013-2018)
6.1.7 Italy Blood Cancer Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Blood Cancer Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Blood Cancer Drugs Sales by Manufacturers (2016-2017)
6.2.2 Europe Blood Cancer Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Blood Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Blood Cancer Drugs Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Blood Cancer Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Blood Cancer Drugs Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Blood Cancer Drugs Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Blood Cancer Drugs Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Blood Cancer Drugs by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Blood Cancer Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Blood Cancer Drugs Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Blood Cancer Drugs Revenue by Countries (2013-2018)
7.1.3 China Blood Cancer Drugs Sales and Growth Rate (2013-2018)
7.1.4 Japan Blood Cancer Drugs Sales and Growth Rate (2013-2018)
7.1.5 Korea Blood Cancer Drugs Sales and Growth Rate (2013-2018)
7.1.6 India Blood Cancer Drugs Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Blood Cancer Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Blood Cancer Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Blood Cancer Drugs Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Blood Cancer Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Blood Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Blood Cancer Drugs Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Blood Cancer Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Blood Cancer Drugs Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Blood Cancer Drugs Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Blood Cancer Drugs Revenue and Revenue Share by Application (2013-2018)
8 South America Blood Cancer Drugs by Countries, Type, Application and Manufacturers
8.1 South America Blood Cancer Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Blood Cancer Drugs Sales by Countries (2013-2018)
8.1.2 South America Blood Cancer Drugs Revenue by Countries (2013-2018)
8.1.3 Brazil Blood Cancer Drugs Sales and Growth Rate (2013-2018)
8.1.4 Argentina Blood Cancer Drugs Sales and Growth Rate (2013-2018)
8.1.5 Colombia Blood Cancer Drugs Sales and Growth Rate (2013-2018)
8.2 South America Blood Cancer Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Blood Cancer Drugs Sales by Manufacturers (2016-2017)
8.2.2 South America Blood Cancer Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Blood Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Blood Cancer Drugs Sales and Sales Share by Type (2013-2018)
8.3.2 South America Blood Cancer Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Blood Cancer Drugs Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Blood Cancer Drugs Sales and Sales Share by Application (2013-2018)
8.4.2 South America Blood Cancer Drugs Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Blood Cancer Drugs by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Blood Cancer Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Blood Cancer Drugs Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Blood Cancer Drugs Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Blood Cancer Drugs Sales and Growth Rate (2013-2018)
9.1.4 UAE Blood Cancer Drugs Sales and Growth Rate (2013-2018)
9.1.5 Egypt Blood Cancer Drugs Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Blood Cancer Drugs Sales and Growth Rate (2013-2018)
9.1.7 South Africa Blood Cancer Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Blood Cancer Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Blood Cancer Drugs Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Blood Cancer Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Blood Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Blood Cancer Drugs Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Blood Cancer Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Blood Cancer Drugs Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Blood Cancer Drugs Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Blood Cancer Drugs Revenue and Revenue Share by Application (2013-2018)
10 Global Blood Cancer Drugs Market Segment by Type
10.1 Global Blood Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Blood Cancer Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Blood Cancer Drugs Revenue and Market Share by Type (2013-2018)
10.2 Blood Chemotherapy Drugs Sales Growth and Price
10.2.1 Global Blood Chemotherapy Drugs Sales Growth (2013-2018)
10.2.2 Global Blood Chemotherapy Drugs Price (2013-2018)
10.3 Blood Targeted Therapy Drugs Sales Growth and Price
10.3.1 Global Blood Targeted Therapy Drugs Sales Growth (2013-2018)
10.3.2 Global Blood Targeted Therapy Drugs Price (2013-2018)
11 Global Blood Cancer Drugs Market Segment by Application
11.1 Global Blood Cancer Drugs Sales Market Share by Application (2013-2018)
11.2 Leukemia Sales Growth (2013-2018)
11.3 lymphoma Sales Growth (2013-2018)
11.4 Multiple Myeloma Sales Growth (2013-2018)
12 Blood Cancer Drugs Market Forecast (2018-2023)
12.1 Global Blood Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Blood Cancer Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Blood Cancer Drugs Market Forecast (2018-2023)
12.2.2 Europe Blood Cancer Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Blood Cancer Drugs Market Forecast (2018-2023)
12.2.4 South America Blood Cancer Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Blood Cancer Drugs Market Forecast (2018-2023)
12.3 Blood Cancer Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Blood Cancer Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Blood Cancer Drugs Market Share Forecast by Type (2018-2023)
12.4 Blood Cancer Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Blood Cancer Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Blood Cancer Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Blood Cancer Drugs Picture
Table Product Specifications of Blood Cancer Drugs
Figure Global Blood Cancer Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Blood Cancer Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Blood Cancer Drugs by Types in 2017
Figure Blood Chemotherapy Drugs Picture
Table Major Manufacturers of Blood Chemotherapy Drugs
Figure Blood Targeted Therapy Drugs Picture
Table Major Manufacturers of Blood Targeted Therapy Drugs
Figure Blood Cancer Drugs Sales Market Share by Applications in 2017
Figure Leukemia Picture
Figure lymphoma Picture
Figure Multiple Myeloma Picture
Figure United States Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Blood Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Amgen Inc, Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Inc, Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
Table Amgen Inc, Blood Cancer Drugs Product
Table Amgen Inc, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Inc, Blood Cancer Drugs Sales Market Share in 2017
Figure Global Amgen Inc, Blood Cancer Drugs Revenue Market Share in 2017
Table AstraZeneca PLC, Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca PLC, Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
Table AstraZeneca PLC, Blood Cancer Drugs Product
Table AstraZeneca PLC, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca PLC, Blood Cancer Drugs Sales Market Share in 2017
Figure Global AstraZeneca PLC, Blood Cancer Drugs Revenue Market Share in 2017
Table Astellas Pharma Inc, Headquarter, Established, Main Business and Finance Overview (2017)
Table Astellas Pharma Inc, Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
Table Astellas Pharma Inc, Blood Cancer Drugs Product
Table Astellas Pharma Inc, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Astellas Pharma Inc, Blood Cancer Drugs Sales Market Share in 2017
Figure Global Astellas Pharma Inc, Blood Cancer Drugs Revenue Market Share in 2017
Table Bayer AG, Headquarter, Established, Main Business and Finance Overview (2017)
Table Bayer AG, Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
Table Bayer AG, Blood Cancer Drugs Product
Table Bayer AG, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bayer AG, Blood Cancer Drugs Sales Market Share in 2017
Figure Global Bayer AG, Blood Cancer Drugs Revenue Market Share in 2017
Table Bristol-Myers Squibb Company, Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol-Myers Squibb Company, Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
Table Bristol-Myers Squibb Company, Blood Cancer Drugs Product
Table Bristol-Myers Squibb Company, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol-Myers Squibb Company, Blood Cancer Drugs Sales Market Share in 2017
Figure Global Bristol-Myers Squibb Company, Blood Cancer Drugs Revenue Market Share in 2017
Table Celgene Corporation, Headquarter, Established, Main Business and Finance Overview (2017)
Table Celgene Corporation, Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
Table Celgene Corporation, Blood Cancer Drugs Product
Table Celgene Corporation, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Celgene Corporation, Blood Cancer Drugs Sales Market Share in 2017
Figure Global Celgene Corporation, Blood Cancer Drugs Revenue Market Share in 2017
Table Eli Lilly, Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly, Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
Table Eli Lilly, Blood Cancer Drugs Product
Table Eli Lilly, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly, Blood Cancer Drugs Sales Market Share in 2017
Figure Global Eli Lilly, Blood Cancer Drugs Revenue Market Share in 2017
Table F.Hoffmann-La Roche Ltd., Headquarter, Established, Main Business and Finance Overview (2017)
Table F.Hoffmann-La Roche Ltd., Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
Table F.Hoffmann-La Roche Ltd., Blood Cancer Drugs Product
Table F.Hoffmann-La Roche Ltd., Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global F.Hoffmann-La Roche Ltd., Blood Cancer Drugs Sales Market Share in 2017
Figure Global F.Hoffmann-La Roche Ltd., Blood Cancer Drugs Revenue Market Share in 2017
Table Johnson & Johnson, Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson, Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson, Blood Cancer Drugs Product
Table Johnson & Johnson, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson, Blood Cancer Drugs Sales Market Share in 2017
Figure Global Johnson & Johnson, Blood Cancer Drugs Revenue Market Share in 2017
Table Novartis, Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis, Blood Cancer Drugs Production Bases, Sales Regions and Major Competitors
Table Novartis, Blood Cancer Drugs Product
Table Novartis, Blood Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis, Blood Cancer Drugs Sales Market Share in 2017
Figure Global Novartis, Blood Cancer Drugs Revenue Market Share in 2017
Table Pfizer Inc,
Table Pfizer Inc, Blood Cancer Drugs
Table Takeda Pharmaceutical Company Ltd,
Table Takeda Pharmaceutical Company Ltd, Blood Cancer Drugs
Table AbbVie Inc.
Table AbbVie Inc. Blood Cancer Drugs
Table Global Blood Cancer Drugs Sales by Manufacturer (2016-2017)
Figure Global Blood Cancer Drugs Sales Market Share by Manufacturer in 2016
Figure Global Blood Cancer Drugs Sales Market Share by Manufacturer in 2017
Table Global Blood Cancer Drugs Revenue by Manufacturer (2016-2017)
Figure Global Blood Cancer Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Blood Cancer Drugs Revenue Market Share by Manufacturer in 2017
Table Global Blood Cancer Drugs Price by Manufacturer (2016-2017)
Figure Top 3 Blood Cancer Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Blood Cancer Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Blood Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Global Blood Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Global Blood Cancer Drugs Sales by Regions (2013-2018)
Table Global Blood Cancer Drugs Sales Market Share by Regions (2013-2018)
Table Global Blood Cancer Drugs Revenue by Regions (2013-2018)
Figure Global Blood Cancer Drugs Revenue Market Share by Regions in 2013
Figure Global Blood Cancer Drugs Revenue Market Share by Regions in 2017
Figure North America Blood Cancer Drugs Sales and Growth Rate (2013-2018)
Figure North America Blood Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Blood Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Europe Blood Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Blood Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Blood Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure South America Blood Cancer Drugs Sales and Growth Rate (2013-2018)
Figure South America Blood Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Blood Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Blood Cancer Drugs Revenue and Growth Rate (2013-2018)
Figure North America Blood Cancer Drugs Revenue and Growth Rate (2013-2018)
Table North America Blood Cancer Drugs Sales by Countries (2013-2018)
Table North America Blood Cancer Drugs Sales Market Share by Countries (2013-2018)
Figure North America Blood Cancer Drugs Sales Market Share by Countries in 2013
Figure North America Blood Cancer Drugs Sales Market Share by Countries in 2017
Table North America Blood Cancer Drugs Revenue by Countries (2013-2018)
Table North America Blood Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Blood Cancer Drugs Revenue Market Share by Countries in 2013
Figure North America Blood Cancer Drugs Revenue Market Share by Countries in 2017
Figure United States Blood Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Canada Blood Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Blood Cancer Drugs Sales and Growth Rate (2013-2018)
Table North America Blood Cancer Drugs Sales by Manufacturer (2016-2017)
Figure North America Blood Cancer Drugs Sales Market Share by Manufacturer in 2016
Figure North America Blood Cancer Drugs Sales Market Share by Manufacturer in 2017
Table North America Blood Cancer Drugs Revenue by Manufacturer (2016-2017)
Figure North America Blood Cancer Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Blood Cancer Drugs Revenue Market Share by Manufacturer in 2017
Table North America Blood Cancer Drugs Sales by Type (2013-2018)
Table North America Blood Cancer Drugs Sales Share by Type (2013-2018)
Table North America Blood Cancer Drugs Revenue by Type (2013-2018)
Table North America Blood Cancer Drugs Revenue Share by Type (2013-2018)
Table North America Blood Cancer Drugs Sales by Application (2013-2018)
Table North America Blood Cancer Drugs Sales Share by Application (2013-2018)
Table North America Blood Cancer Drugs Revenue by Application (2013-2018)
Table North America Blood Cancer Drugs Revenue Share by Application (2013-2018)
Figure Europe Blood Cancer
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
